100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Vonozan is a potassium-competitive acid blocker (P-CAB) that directly inhibits H+, K+-ATPase in gastric parietal cells without needing acid activation. It remains localized at the acid-secreting site, offering potent and sustained acid suppression, and helps prevent upper GI mucosal injury.
H. pylori eradication:
First-line: Vonozan 20 mg + Amoxicillin 750 mg + Clarithromycin 200 mg – twice daily for 7 days
Second-line (if needed): Vonozan 20 mg + Amoxicillin 750 mg + Metronidazole 250 mg – twice daily for 7 days
Can be taken with or without food.
Elderly: Use with caution due to potential organ function decline
Children under 18: Not recommended (safety not established)
Renal Impairment:
Mild–Moderate (eGFR 30–89): No dose change
Severe (eGFR <30): Avoid use
Hepatic Impairment:
Mild (Child-Pugh A): No adjustment needed
Moderate–Severe (Child-Pugh B/C): Avoid use
Hypersensitivity to Vonoprazan or any excipients
Concurrent use with Atazanavir, Nelfinavir, or Rilpivirine
Vonozan should only be used during pregnancy if the benefits outweigh potential risks. If necessary during breastfeeding, consider stopping nursing.
Store below 30°C in a dry, cool, and light-protected place. Keep away from children.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.